Angioscope Device Market

Angioscope Device Market: Global Industry Trend Analysis 2012 to 2017 and Forecast 2017 - 2025

Angioscope Device Market Segmented By Non occlusion angioscope and Occlusion angioscope Type with Procedure such as Coronary, Pulmonary, Cerebral, Extremity and Renal

Industry: Healthcare

Format: PPT*, PDF, EXCEL

Delivery Timelines: Contact Sales

Report Type: Ongoing

Report ID: PMRREP17602

Report Price

$ 4995*

Pre Book

Introduction

Angioscope is an equipment used for visualizing the interior of blood vessels by using a fibre-optic catheter inserted into an artery, composed of a fiberscope, operating part and guiding catheter with or without balloon. It is used for the determination of several diseases such as vascular disease, staging of atherosclerosis and determination of thrombus composition.

A special kind of technique called as dye-image angioscopy is used clinically for analysis of thrombus composition, endothelial damage and plaque composition. Another new technique known as fluorescent image angioscopy is used for detailed description of coronary vessels.

According to the Centres for Disease Control and Prevention, during period of 1995-2015, around 610,000 people die of heart diseases in U.S. every year. Angioscopy is mainly preferred for determining any severe blockage by visualising in 2D or in 3D.

Angioscope Device Market: Drivers & Restraints

Heart diseases such as coronary heart diseases, high blood pressure, cardiac arrest and others have gradually increased which leads to the growth of angioscope device market. Also due to the increasing awareness for heart diseases and its diagnosis, favourable government regulations, commercialization of angioscope devices and aging population with rise in number of life-style diseases are also contributing in the growth of global angioscope device market.

Factors such as absence of reimbursement caused by equipment failure, coping with changing regulations and cost of the angioscope device makes it the major restrain of the angioscope device market depriving of its viability in developing countries regardless of its medical susceptibility.

Angioscope Device Market: Segmentation

Based on Type
  • Non occlusion angioscope
  • Occlusion angioscope
Based on Procedure
  • Coronary
  • Pulmonary
  • Cerebral
  • Extremity
  • Renal
Based on End User
  • Hospitals
  • Diagnostic laboratories
  • Academic and Research institutes
Based on Geography
  • North America
  • Europe
  • Latin America
  • Asia-Pacific
  • Middle East and Africa

Regional Outlook

North America is leading player for global angioscope devices market as it occupies a major share in this market followed by Europe. However, emerging countries like India and China are expected to record strong growth, due to high rise in investments by public & private players for providing improved healthcare services.

As a geography conditions the Angioscope Device Market is segmented into: North America, Latin America, Europe, Asia-Pacific and the Middle East & Africa. North America is considered as the major region in angioscope device market

Key Players

Some players in Angioscope Device Market are Abbott Vascular (Abbott Laboratories), Toshiba Medical Systems Corporation, Royal Philips Electronics, GE Healthcare, Medtronic, Inc., Cordis Corporation, Shimadzu Corporation, and Siemens Healthcare and others.

The report covers exhaustive analysis on:

  • Angioscope Device Market Segments
  • Angioscope Device Market Dynamics
  • Historical Actual Market Size, 2013 - 2016
  • Angioscope Device Market Size & Forecast 2017 to 2025
  • Angioscope Device Market Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Angioscope Device Market Drivers and Restraints

Regional analysis includes

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size Recent industry trends
  • Key Competition landscape
  • Strategies of key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance

To know more about delivery timeline for this report Contact Sales

About Author

Anu Jamwal

Anu Jamwal

Senior Consultant

Anu is a Senior Consultant with over a decade of experience and has developed deep expertise in clinical diagnostics, biotechnology, animal health, healthcare IT, and pharmaceuticals, including pipeline assessment. She has authored comprehensive reports providing both global and regional competitive intelligence. She has also successfully led consulting assignments focused on business strategies, product launches, and medical census studies.

Read More →

Companies Covered in This Report

Thank you for taking time to visit our website, click like if you found the information on this page useful?

This site uses cookies, including third-party cookies, that help us to provide and improve our services.
Google translate